Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9351a1fd2f7ed6e980c0042e0726c2b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
filingDate |
1998-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4c73df0a4697209440c18d33b45688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb380d6eb10d75d4f5ea15ffd14f217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7a13d6994d651f7e165f9f3084773c |
publicationDate |
2000-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-2782010-A1 |
titleOfInvention |
NEW USE OF ARSENIC COMPOUND FOR MEGACYO-CYCLARY OR PLAQUETRY LEUKEMIA |
abstract |
The present invention relates to a new use of an apoptotic substance, characterized in that an arsenic compound is used as an apoptotic substance for the preparation of a medicament intended for use in therapeutic with respect to for hyperproliferative megakaryocytic or platelet disorders, said arsenic compound preferably being As2 O3. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497300-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1166789-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1166789-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026319-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394422-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026319-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6703049-B2 |
priorityDate |
1998-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |